Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

February 01, 1997; Volume 25,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abbott, Frank S.

    1. You have access
      A Comparative Investigation of 2-Propyl-4-Pentenoic Acid (4-ene VPA) and its α-Fluorinated Analogue: Phase II Metabolism and Pharmacokinetics
      Wei Tang and Frank S. Abbott
      Drug Metabolism and Disposition February 1997, 25 (2) 219-227;
  2. Åkesson, Bengt

    1. You have access
      Major Metabolic Pathway for N-Methyl-2-Pyrrolidone in Humans
      Bengt Åkesson and Bo A. g. Jönsson
      Drug Metabolism and Disposition February 1997, 25 (2) 267-269;
  3. Amin, Shantu

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;
  4. Anderson, Wayne

    1. You have access
      Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
      Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
      Drug Metabolism and Disposition February 1997, 25 (2) 206-218;
  5. Avery, Michael J.

    1. You have access
      Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;

B

  1. Barakat, Mouhsine

    1. You have access
      In Vivo, Ex Vivo, and In Vitro Effects ofl-NAME and l-Arginine on the Metabolism of Theophylline in the Rabbit
      Mouhsine Barakat, Ayman O. S. El-Kadi and Patrick Du Souich
      Drug Metabolism and Disposition February 1997, 25 (2) 191-195;
  2. Brennan, Mark D.

    1. You have access
      Human NAD(P)H:Quinone Oxidoreductase Induction in Human Hepatoma Cells after Exposure to Industrial Acrylates, Phenolics, and Metals
      Edward J. Winner, Russell A. Prough and Mark D. Brennan
      Drug Metabolism and Disposition February 1997, 25 (2) 175-181;

C

  1. Chang, Mayland

    1. You have access
      Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;
  2. Collins, Jerry M.

    1. You have access
      Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4
      Michael E. Fitzsimmons and Jerry M. Collins
      Drug Metabolism and Disposition February 1997, 25 (2) 256-266;

D

  1. Dalvie, Deepak

    1. You have access
      Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;
  2. Datta, Kaushik

    1. You have access
      Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
      Kaushik Datta, Paul M. Sherblom and Arun P. Kulkarni
      Drug Metabolism and Disposition February 1997, 25 (2) 196-105;
  3. Dickey, Kenneth M.

    1. You have access
      Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;

E

  1. El-Kadi, Ayman O. S.

    1. You have access
      In Vivo, Ex Vivo, and In Vitro Effects ofl-NAME and l-Arginine on the Metabolism of Theophylline in the Rabbit
      Mouhsine Barakat, Ayman O. S. El-Kadi and Patrick Du Souich
      Drug Metabolism and Disposition February 1997, 25 (2) 191-195;

F

  1. Fagerness, Paul E.

    1. You have access
      Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;
  2. Falkner, Fred C.

    1. You have access
      Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;
  3. Fitzsimmons, Michael E.

    1. You have access
      Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4
      Michael E. Fitzsimmons and Jerry M. Collins
      Drug Metabolism and Disposition February 1997, 25 (2) 256-266;
  4. Fouda, Hassan G.

    1. You have access
      Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;
  5. Fredenburg, Andrea M.

    1. You have access
      Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;

G

  1. Green, Mitchell D.

    1. You have access
      Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;
  2. Guengerich, F. Peter

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;
    2. You have access
      Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;

H

  1. Hauer, Michael J.

    1. You have access
      Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;
  2. Hecht, Stephen S.

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;
  3. Hollenberg, Paul F.

    1. You have access
      Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;
  4. Hong, Chuen B.

    1. You have access
      Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;
  5. Howard, Harry

    1. You have access
      Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
      Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
      Drug Metabolism and Disposition February 1997, 25 (2) 206-218;

I

  1. Ikeda, Kazumasa

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  2. Inoue, Kiyoshi

    1. You have access
      Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;
  3. Ishii, Yuji

    1. You have access
      Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;

J

  1. Johnson, Eric F.

    1. You have access
      Diazepam Metabolism by cDNA-Expressed Human 2C P450s
      Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
      Drug Metabolism and Disposition February 1997, 25 (2) 133-139;
  2. Jönsson, Bo A. g.

    1. You have access
      Major Metabolic Pathway for N-Methyl-2-Pyrrolidone in Humans
      Bengt Åkesson and Bo A. g. Jönsson
      Drug Metabolism and Disposition February 1997, 25 (2) 267-269;
  3. Jung, Frank

    1. You have access
      Diazepam Metabolism by cDNA-Expressed Human 2C P450s
      Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
      Drug Metabolism and Disposition February 1997, 25 (2) 133-139;

K

  1. Kamel, Amin

    1. You have access
      Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
      Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
      Drug Metabolism and Disposition February 1997, 25 (2) 206-218;
  2. Kanazu, Takushi

    1. You have access
      Comparison of in Vitro Carnitine and Glycine Conjugation with Branched-Side Chain and Cyclic Side Chain Carboxylic Acids in Rats
      Takushi Kanazu and Toshiro Yamaguchi
      Drug Metabolism and Disposition February 1997, 25 (2) 149-153;
  3. Kawaguchi, Yasuro

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  4. Kent, Ute M.

    1. You have access
      Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;
  5. King, Christopher D.

    1. You have access
      Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;
  6. Kloosterman, David A.

    1. You have access
      Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;
  7. Koehl, Werner

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;
  8. Koenig, Leeann A.

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;
  9. Kulkarni, Arun P.

    1. You have access
      Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
      Kaushik Datta, Paul M. Sherblom and Arun P. Kulkarni
      Drug Metabolism and Disposition February 1997, 25 (2) 196-105;
  10. Kurogi, Akiko

    1. You have access
      Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;

M

  1. Mackenzie, Peter I.

    1. You have access
      Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;
  2. Melvin, Lawrence S.

    1. You have access
      Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;
  3. Meurer, Kathryn A.

    1. You have access
      Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;
  4. Murphy, Sharon E.

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

N

  1. Nagayama, Sekio

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  2. Nakamura, Yoshimasa

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  3. Nishiyama, Takahito

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  4. Nunes, Maria G.

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

O

  1. Ogura, Kenichiro

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  2. Oguri, Kazuta

    1. You have access
      Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;
  3. Okuda, Haruhiro

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  4. Owens, S. Michael

    1. You have access
      Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;

P

  1. Patten, Christopher J.

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;
  2. Prakash, Chandra

    1. You have access
      Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
      Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
      Drug Metabolism and Disposition February 1997, 25 (2) 206-218;
  3. Prough, Russell A.

    1. You have access
      Human NAD(P)H:Quinone Oxidoreductase Induction in Human Hepatoma Cells after Exposure to Industrial Acrylates, Phenolics, and Metals
      Edward J. Winner, Russell A. Prough and Mark D. Brennan
      Drug Metabolism and Disposition February 1997, 25 (2) 175-181;

R

  1. Raucy, Judy L.

    1. You have access
      Diazepam Metabolism by cDNA-Expressed Human 2C P450s
      Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
      Drug Metabolism and Disposition February 1997, 25 (2) 133-139;
  2. Richardson, Toby H.

    1. You have access
      Diazepam Metabolism by cDNA-Expressed Human 2C P450s
      Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
      Drug Metabolism and Disposition February 1997, 25 (2) 133-139;
  3. Rios, Gladys R.

    1. You have access
      Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;
  4. Roberts, Elizabeth S.

    1. You have access
      Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;
  5. Ronfeld, Robert A.

    1. You have access
      Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;

S

  1. Sanders, Phillip E.

    1. You have access
      Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;
  2. Sharma, Uma

    1. You have access
      Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;
  3. Sherblom, Paul M.

    1. You have access
      Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
      Kaushik Datta, Paul M. Sherblom and Arun P. Kulkarni
      Drug Metabolism and Disposition February 1997, 25 (2) 196-105;
  4. Shimada, Tsutomu

    1. You have access
      Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;
  5. Skinner, Thomas L.

    1. You have access
      Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;
  6. Sood, Virendra K.

    1. You have access
      Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;
  7. Souich, Patrick Du

    1. You have access
      In Vivo, Ex Vivo, and In Vitro Effects ofl-NAME and l-Arginine on the Metabolism of Theophylline in the Rabbit
      Mouhsine Barakat, Ayman O. S. El-Kadi and Patrick Du Souich
      Drug Metabolism and Disposition February 1997, 25 (2) 191-195;
  8. Staretz, Marianne E.

    1. You have access
      Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

T

  1. Takami, Atsuko

    1. You have access
      Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;
  2. Tang, Wei

    1. You have access
      A Comparative Investigation of 2-Propyl-4-Pentenoic Acid (4-ene VPA) and its α-Fluorinated Analogue: Phase II Metabolism and Pharmacokinetics
      Wei Tang and Frank S. Abbott
      Drug Metabolism and Disposition February 1997, 25 (2) 219-227;
  3. Tephly, Thomas R.

    1. You have access
      Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;
  4. Tsuruda, Kazuoki

    1. You have access
      Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;
  5. Turvy, Connie G.

    1. You have access
      Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;

W

  1. Watabe, Tadashi

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  2. Wilson, Gracella J.

    1. You have access
      Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;
  3. Winner, Edward J.

    1. You have access
      Human NAD(P)H:Quinone Oxidoreductase Induction in Human Hepatoma Cells after Exposure to Industrial Acrylates, Phenolics, and Metals
      Edward J. Winner, Russell A. Prough and Mark D. Brennan
      Drug Metabolism and Disposition February 1997, 25 (2) 175-181;

Y

  1. Yamada, Hideyuki

    1. You have access
      Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;
  2. Yamaguchi, Shuji

    1. You have access
      Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;
  3. Yamaguchi, Toshiro

    1. You have access
      Comparison of in Vitro Carnitine and Glycine Conjugation with Branched-Side Chain and Cyclic Side Chain Carboxylic Acids in Rats
      Takushi Kanazu and Toshiro Yamaguchi
      Drug Metabolism and Disposition February 1997, 25 (2) 149-153;
  4. Yamazaki, Hiroshi

    1. You have access
      Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;
  5. Yokel, Robert A.

    1. You have access
      Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 2
1 Feb 1997
  • Table of Contents
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics